Venlafaxine SR vs ER: Key Differences
There is no clinically meaningful difference between venlafaxine "SR" (sustained-release) and "ER" (extended-release) formulations—these terms are used interchangeably to describe the same once-daily, long-acting formulation of venlafaxine. The confusion arises from inconsistent terminology in the literature, but both refer to the extended-release capsule formulation that replaced the original immediate-release (IR) tablets.
Understanding the Formulation Evolution
The critical distinction is between immediate-release (IR) and extended-release (ER/XR/SR) formulations, not between SR and ER:
Immediate-Release (IR) Formulation
- Requires twice or thrice-daily dosing due to short elimination half-life 1
- Higher peak plasma concentrations (Cmax) reached earlier (lower Tmax) 2
- Associated with more nausea and dizziness at treatment initiation 2, 3
- Typical dosing: 37.5 mg twice daily, titrated up to 75-225 mg/day in divided doses 4
Extended-Release (ER/XR/SR) Formulation
- Once-daily dosing due to longer apparent elimination half-life 1, 2
- Lower maximum plasma concentrations with delayed time to peak 2
- Better tolerated with less nausea and dizziness during initiation 2, 3
- Same total drug exposure as IR but with smoother plasma concentration curves 2, 5
- Typical dosing: 75 mg once daily, can increase to 150-225 mg/day 4
Clinical Implications
Efficacy is equivalent between IR and ER formulations—there is no increase in the therapeutic effect of the active agent 2. However, the ER formulation offers practical advantages:
- Improved compliance due to simplified once-daily dosing 2, 5
- Reduced side effects at treatment initiation, particularly nausea (the most common adverse effect) 3
- Lower risk of discontinuation symptoms due to more stable plasma levels, though this requires further comparative study 2
Dosing Considerations
When prescribing venlafaxine ER:
- Start at 75 mg once daily (taken with food)
- Increase by 75 mg increments at intervals of no less than 4 days 4
- Therapeutic range: 150-225 mg/day for most patients 6
- Maximum dose: 375 mg/day for severely depressed patients 4
Important caveat: The FDA label specifies that venlafaxine is available in "short- and long-acting preparations" 6, confirming that SR/ER/XR all refer to the long-acting formulation, while IR is the short-acting version.
Bottom Line
If you encounter both "SR" and "ER" terminology, treat them as the same formulation. The meaningful clinical choice is between immediate-release (requiring multiple daily doses with more side effects) versus extended-release (once-daily with better tolerability). Always prescribe the extended-release formulation unless there is a specific reason to use immediate-release, as it provides equivalent efficacy with superior tolerability and convenience 2, 3, 5.